{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:24:09Z","timestamp":1793046249595,"version":"4.5.0"},"reference-count":17,"publisher":"Massachusetts Medical Society","issue":"15","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["NCI contract 75N91019D00024"],"award-info":[{"award-number":["NCI contract 75N91019D00024"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["NIAID HHSN272201800013C"],"award-info":[{"award-number":["NIAID HHSN272201800013C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2025,4,17]]},"DOI":"10.1056\/nejmoa2412439","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T17:00:41Z","timestamp":1744822841000},"page":"1484-1496","source":"Crossref","is-referenced-by-count":138,"title":["Tecovirimat for Clade I MPXV Infection in the Democratic Republic of Congo"],"prefix":"10.1056","volume":"392","author":[{"name":"The PALM007 Writing Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03130-3"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1005769107"},{"key":"e_1_3_4_4_2","unstructured":"Fenner F Henderson DA Arita I et al. Smallpox and its eradication. Geneva: World Health Organization 1988 (https:\/\/iris.who.int\/handle\/10665\/39485)."},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705688"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-6-44"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01689-09"},{"key":"e_1_3_4_8_2","unstructured":"World Health Organization. Multi-country outbreak of mpox external situation report #31. December 22 2023 (https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-mpox--external-situation-report-31---22-december-2023)."},{"key":"e_1_3_4_9_2","unstructured":"World Health Organization. Mpox (monkeypox) outbreak. 2022 (https:\/\/www.who.int\/emergencies\/situations\/monkeypox-oubreak-2022)."},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","unstructured":"Bangwen E Diavita R De Vos E et al. Mpox in the Democratic Republic of the Congo: analysis of national epidemiological and laboratory surveillance data 2010\u20132023. Lancet. September 19 2024 (https:\/\/papers.ssrn.com\/sol3\/papers.cfm?abstract_id=4954317). preprint.","DOI":"10.2139\/ssrn.4954317"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid3001.231164"},{"key":"e_1_3_4_12_2","unstructured":"World Health Organization. WHO director-geneeral declares mpox outbreak a public health emergency of international concern. August 14 2024 (https:\/\/www.who.int\/news\/item\/14-08-2024-who-director-general-declares-mpox-outbreak-a-public-health-emergency-of-international-concern)."},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0010384"},{"key":"e_1_3_4_14_2","unstructured":"Muyembe-Tamfum J-J. Clinical aspects of monkeypox in DR Congo: monkeypox epidemiology surveillance and laboratory capacity in DRC. Geneva: World Health Organization 2007 (https:\/\/cdn.who.int\/media\/docs\/default-source\/blue-print\/day-1_jean-jacques-muyembe_drc_monkeypox-meeting_02june2022.pdf?sfvrsn=d133676a_3)."},{"key":"e_1_3_4_15_2","unstructured":"Center for Drug Evaluation and Research. Clinical Pharmacology and biopharmaceutics review(s). Tecovirimat (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/208627Orig1s000ClinPharmR.pdf)."},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1999.10474144"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/1740774520939938"},{"key":"e_1_3_4_18_2","unstructured":"Wei Z Aldrovandi G Currier J et al. Pharmacokinetics of tecovirimat in persons with mpox: results from ACTG. Presented at the 31st Conference on Retroviruses and Opportunistic Infections (CROI 2024) Denver March 3\u20136 2024. poster."}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa2412439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T19:52:05Z","timestamp":1749239525000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa2412439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":17,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,4,17]]}},"alternative-id":["10.1056\/NEJMoa2412439"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa2412439","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}